Healthcare Sales & Marketing Network News: Blood Glucose

Searching News Database: Blood Glucose

HSMN NewsFeed - 10 Jun 2024
Abbott Receives U.S. FDA Clearance for Two New Over-the-Counter Continuous Glucose Monitoring Systems
Devices Endocrinology Monitoring FDA

HSMN NewsFeed - 1 Mar 2024
Mallinckrodt Announces U.S. FDA Approval of Supplemental New Drug Application for Acthar(R) Gel (repository corticotropin injection) Single-Dose Pre-filled SelfJect(TM) Injector
Devices Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 8 Jan 2024
Medtronic Diabetes announces world's first approval for MiniMed(TM) 780G System with Simplera Sync(TM) disposable, all-in-one sensor
Devices Monitoring Regulatory

HSMN NewsFeed - 6 Oct 2023
Amgen Completes Acquisition of Horizon Therapeutics plc
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 29 Jun 2023
Lilly to Acquire Sigilon Therapeutics
Biopharmaceuticals Endocrinology Mergers & Acquisitions

HSMN NewsFeed - 18 May 2023
Endogenex(TM) Appoints Christopher Sorli as Chief Medical Officer
Devices Personnel

HSMN NewsFeed - 31 May 2022
Abbott's FreeStyle Libre(R) 3 Receives U.S. FDA Clearance - Features World's Smallest, Thinnest and Most Accurate 14-Day Glucose Sensor
Devices Endocrinology Monitoring FDA

HSMN NewsFeed - 27 Apr 2022
New Studies Demonstrate Clinical Benefits of Patient-and Provider-Supportive Technology in Diabetes Management
Devices Monitoring Endocrinology

HSMN NewsFeed - 24 Mar 2022
Abbott's FreeStyle(R) Libre is First and Only CGM System to Gain Expanded Reimbursement in Japan to Include All People with Diabetes Who Use Insulin
Devices Monitoring Reimbursement

HSMN NewsFeed - 16 Mar 2022
Glooko Acquires DIABNEXT(R) to Expand Diabetes Offerings in France
Devices Monitoring Endocrinology Mergers & Acquisitions

HSMN NewsFeed - 24 Aug 2021
Smart Meter Announces Launch of iGlucose Blood Glucose Monitoring (BGM) System for Use in Managing Gestational Diabetes
Devices Monitoring Endocrinology Product Launch

HSMN NewsFeed - 2 Aug 2021
Abbott's FreeStyle(R) Libre 2 iOS App Cleared in U.S., Providing a Seamless Digital Experience to Simplify Diabetes Management
Devices Monitoring Endocrinology FDA

HSMN NewsFeed - 26 May 2021
Medtronic Secures Two CE Mark Approvals for Guardian 4 Sensor & for InPen MDI Smart Insulin Pen
Devices Drug Delivery Endocrinology Regulatory

HSMN NewsFeed - 19 May 2021
Roche launches mySugr Pump Control within the mySugr app to simplify insulin pump therapy via smartphone
Devices Endocrinology Product Launch

HSMN NewsFeed - 6 May 2021
Lilly collaborates internationally with leading diabetes technology companies to integrate connected insulin pen solutions for people with diabetes
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 26 Mar 2021
European Medicines Agency Accepts Marketing Authorization Application for Enfortumab Vedotin
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 2 Mar 2021
ViaCyte and Gore Expand Collaboration to Develop Novel Membrane and Device Technologies that Enhance Delivery of Cell Replacement Therapies for Diabetes
Regenerative Medicine Endocrinology

HSMN NewsFeed - 25 Feb 2021
Welldoc and Lilly collaborate to integrate BlueStar(R) app capabilities into Lilly's connected insulin solutions
Biopharmaceuticals Endocrinology Licensing

HSMN NewsFeed - 24 Feb 2021
Clarus Therapeutics Appoints Richard 'Ric' Peterson as Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Dec 2020
Abbott's FreeStyle Libre 2 Now Approved for Adults and Children with Diabetes in Canada, Featuring Unsurpassed 14-Day Accuracy and Optional Alarms
Devices Monitoring Endocrinology Regulatory

HSMN NewsFeed - 5 Nov 2020
LifeScan Names Lisa Rose Chief Marketing Officer
Devices Monitoring Personnel

HSMN NewsFeed - 1 Sep 2020
Abbott's FreeStyle(R) Libre 2 iCGM System Now Available to Medicare Beneficiaries
Devices Monitoring Endocrinology Reimbursement

HSMN NewsFeed - 31 Aug 2020
Mylan and Biocon Biologics Announce Launch of Semglee(TM) (insulin glargine injection) in the U.S. to Expand Access for Patients Living with Diabetes
Biopharmaceuticals Generics Product Launch

HSMN NewsFeed - 15 Jun 2020
Abbott's FreeStyle(R) Libre 2 iCGM Cleared in U.S. for Adults and Children with Diabetes, Achieving Highest Level of Accuracy and Performance Standards
Devices Monitoring Endocrinology FDA

HSMN NewsFeed - 26 Feb 2020
Oramed Reports Positive Results in the Final Cohort of Its Phase 2b Oral Insulin Trial
Biopharmaceuticals Drug Delivery Endocrinology

HSMN NewsFeed - 19 Feb 2020
Astellas and Seattle Genetics Receive FDA Breakthrough Therapy Designation for PADCEV(TM) (enfortumab vedotin-ejfv) in Combination with Pembrolizumab in First-Line Advanced Bladder Cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 19 Feb 2020
Abbott and Insulet Partner to Integrate Next-Generation Glucose Sensing and Automated Insulin Delivery Technologies for Seamless Diabetes Care
Devices Monitoring Drug Delivery Endocrinology

HSMN NewsFeed - 28 Jan 2020
Lilly plans donation of 200,000 insulin KwikPens over next three years to support lower-income communities
Biopharmaceuticals Drug Delivery Endocrinology

HSMN NewsFeed - 16 Dec 2019
Lilly to Integrate Dexcom CGM into Personalized Diabetes Management System
Devices Drug Delivery Monitoring Endocrinology

HSMN NewsFeed - 13 Sep 2019
Abbott's Revolutionary FreeStyle(R) Libre System Now Reimbursed in the Two Largest Provinces in Canada
Devices Monitoring Endocrinology Reimbursement

HSMN NewsFeed - 27 Jun 2019
ViaCyte Appoints Sandra E. Poole to Board of Directors
Regenerative Medicine Personnel

HSMN NewsFeed - 26 Jun 2019
DayTwo Secures $31 Million In Series B Financing To Scale Microbiome Research Platform To Address Chronic Health Conditions
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 30 May 2019
Whole Biome Secures $35 Million in Series B Financing for Expansion of its Microbiome Discovery Platform and Commercialization of its First Product
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 9 Apr 2019
Alkermes Announces Positive Topline Results From Innovative Study of ARISTADA(R) and INVEGA SUSTENNA(R) for the Treatment of Schizophrenia
Biopharmaceuticals

HSMN NewsFeed - 8 Apr 2019
LifeScan Names Brian Heald as its New Head of Product
Devices Diagnostics Personnel

HSMN NewsFeed - 20 Feb 2019
Hygieia Receives 510(k) Clearance from FDA for Phone App That Enhances Company's d-Nav Insulin Guidance Service
Devices Endocrinology FDA

HSMN NewsFeed - 8 Feb 2019
OneTouch(R) Blood Glucose Monitoring System Accuracy Proven in New Long-Term Study
Devices Diagnostics Monitoring Endcrinology

HSMN NewsFeed - 29 Jan 2019
ViaCyte Announces New Board Members
Regenerative Medicine Personnel

HSMN NewsFeed - 29 Nov 2018
ViaCyte Secures $80 Million Financing to Advance Functional Cures for Insulin-Requiring Diabetes
Regenerative Medicine Endocrinology Venture Capital

HSMN NewsFeed - 25 Oct 2018
89Bio Launches into Liver and Metabolic Disorders with $60 Million Series A Financing
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 2 Oct 2018
Results from Two Phase 3 Studies Show Lilly's Ultra Rapid Lispro (URLi) Met Primary Efficacy Endpoint in People with Type 1 and Type 2 Diabetes
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 25 Sep 2018
CONTOUR(R)NEXT Blood Glucose Monitoring System Tops the List in Recently Published Independent Accuracy Assessment by Diabetes Technology Society
Devices Monitoring Endocrinology

HSMN NewsFeed - 17 Sep 2018
Livongo Announces First Cellular-Enabled Blood Pressure Monitoring System in U.S.
Devices Cardiology Product Launch

HSMN NewsFeed - 26 Mar 2018
DarioHealth Receives U.S. FDA Clearance for iPhone 7, 8 and iPhone X Smart Glucose Meter
Devices Monitoring Endocrinology FDA

HSMN NewsFeed - 16 Mar 2018
Johnson & Johnson Announces Binding Offer from Platinum Equity to Acquire LifeScan, Inc.
Devices Monitoring Endocrinology Acquisitions

HSMN NewsFeed - 12 Mar 2018
Medtronic Receives FDA Approval for Guardian Connect Continuous Glucose Monitoring (CGM) System for People Living with Diabetes
Devices Monitoring Endocrinology FDA

HSMN NewsFeed - 23 Feb 2018
VoCare Develops the World's First Mobile Professional Grade Medical Multi-Diagnostic Device, Which Provides a Revolutionary Integrated Mobile Point-of-Care Solution as Well as a Remote Patient Monitoring Solution
Devices Monitoring

HSMN NewsFeed - 7 Feb 2018
Abbott's App for FreeStyle(R) Libre System Now Available in Europe for Both iPhone and Android
Devices Monitoring Endocrinology Product Launch

HSMN NewsFeed - 8 Jan 2018
Intuity Medical Obtains $70M in Funding From Existing Investors and Hercules Capital
Diagnostics Monitoring Endocrinology Venture Capital

HSMN NewsFeed - 28 Dec 2017
Integrity Applications Signs Distribution Agreement for Its GlucoTrack(R) Non-Invasive Glucose Monitoring Device in the Netherlands
Devices Endocrinology Distribution

HSMN NewsFeed - 14 Dec 2017
Companion Medical Announces U.S. Commercial Launch of Smart Insulin Pen System
Devices Drug Delivery Endocrinology Product Launch

HSMN NewsFeed - 18 Oct 2017
DarioHealth Gains CE Mark for iPhone 7 and iPhone 8 Smart Glucose Meter
Devices Monitoring Endocrinology Regulatory

HSMN NewsFeed - 5 Oct 2017
Animas Corporation to Close Operations and Exit Insulin Pump Market
Devices Endocrinology

HSMN NewsFeed - 15 Aug 2017
Lexicon Pharmaceuticals Reports Additional Positive Data From Pivotal Phase 3 inTandem2 Study Of Sotagliflozin
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 3 Aug 2017
VM BioPharma Announces First Patient Dosed in Phase 3 Study of Gene Therapy Candidate VM202 for Non-Healing Diabetic Foot Ulcers
Biopharmaceuticals Wound Care

HSMN NewsFeed - 8 Jun 2017
Lilly Announces Strategic Collaboration with KeyBioscience AG
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 8 May 2017
Abbott Announces National Reimbursement for FreeStyle(R) Libre in France, Providing Access to Revolutionary Technology for People with Diabetes
Diagnostics Endocrinology Reimbursement

HSMN NewsFeed - 18 Apr 2017
Eiger Announces Industry Veteran Lisa Porter, M.D. to Lead Development of Exendin 9-39 for the Treatment of Post-Bariatric Hypoglycemia
Biopharmaceuticals Gastroenterology Surgery Personnel

HSMN NewsFeed - 10 Nov 2016
Intuity Medical Closes $40M Series 3 Financing
Devices Monitoring Endocrinology Venture Capital

HSMN NewsFeed - 8 Nov 2016
Orexigen Therapeutics Announces Commercialization and Distributorship Agreement with Valeant for Contrave(R) (naltrexone HCl / bupropion HCl extended release) in Australia and New Zealand
Biopharmaceuticals Distribution

HSMN NewsFeed - 8 Nov 2016
BD Launches First Syringe Designed for Use with Humulin(R) R U-500 Insulin
Devices Drug Delivery Endocrinology Product Launch

HSMN NewsFeed - 10 Oct 2016
First Positive Phase 3 Results in Adjuvant Setting for Renal Cell Carcinoma Show SUTENT(R) (sunitinib) Extended Disease Free Survival After Surgical Removal
Biopharmaceuticals Oncology

HSMN NewsFeed - 21 Sep 2016
U.S. FDA Approves INVOKAMET(R) XR (Canagliflozin / Metformin Hydrochloride Extended-Release) for the Treatment of Adults with Type 2 Diabetes
Biopharmaceuticals Endocrinology FDA

HSMN NewsFeed - 21 Jul 2016
LabStyle Innovations Corp. Executes Distribution Partnership with GEMCO Medical
Devices Monitoring Distribution

HSMN NewsFeed - 8 Jun 2016
Orexigen Therapeutics Reports Favorable Markman Ruling in Contrave(R) Patent Litigation
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 26 Apr 2016
Intuity Medical Receives FDA Clearance to Market POGO(R) Automatic(TM) Blood Glucose Monitoring System
Diagnostics Devices Monitoring Endocrinology FDA

HSMN NewsFeed - 17 Feb 2016
New OneTouch Verio Flex(TM) Blood Glucose Meter Takes the Guesswork Out of Blood Sugar Test Results
Devices Monitoring Endocrinology Product Launch

HSMN NewsFeed - 16 Feb 2016
Abbott Receives Approval in Australia for FreeStyle(R) Libre--the Revolutionary Glucose Monitoring System for People with Diabetes
Devices Endocrinology Monitoring Regulatory

HSMN NewsFeed - 28 Jan 2016
DECN Assesses Its Recent Landmark Legal Victories Over Diabetes Division Of Johnson & Johnson
Devices Diagnostics Litigation

HSMN NewsFeed - 26 Jan 2016
Novo Nordisk Launches Tresiba(R) (insulin degludec injection 200 Units/mL) in the United States
Biopharmaceuticals Endocrinology Product Launch

HSMN NewsFeed - 11 Jan 2016
FDA Approves Animas(R) Vibe(R) Insulin Pump and Continuous Glucose Monitoring System For Use in Children
Devices Endocrinology Monitoring FDA

HSMN NewsFeed - 22 Dec 2015
LabStyle Innovations Receives U.S. FDA Marketing Clearance for the Dario Blood Glucose Monitoring System
Devices Monitoring Endocrinology FDA

HSMN NewsFeed - 23 Nov 2015
Akers Biosciences Appoints Medical Technology Specialist as CEO
Diagnostics Personnel

HSMN NewsFeed - 25 Aug 2015
FDA Approves Dexcom G5(R) Mobile Continuous Glucose Monitoring System
Devices Monitoring Endocrinology FDA

HSMN NewsFeed - 20 Aug 2015
Jardiance(R) Demonstrated Cardiovascular (CV) Risk Reduction in People with Type 2 Diabetes at High Risk for CV Events
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 1 Jul 2015
GlySure Secures CE Mark and Launches World’s First Continuous Intravascular Glucose Monitoring System
Devices Monitoring Regulatory

HSMN NewsFeed - 10 Jun 2015
Panasonic Healthcare and Bayer Diabetes Care to Create Leading Global Diabetes Care Solutions Business
Biopharmaceuticals Endocrinology Mergers & Acquisitions

HSMN NewsFeed - 18 Mar 2015
Nimbus Therapeutics Raises $43 Million in Series B Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 18 Feb 2015
Dance Biopharm Completes $9.5 Million Private Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 16 Dec 2014
Novartis gains FDA approval for Signifor(R) LAR to treat patients with acromegaly, a rare and life-threatening hormonal disorder
Biopharmaceuticals FDA

HSMN NewsFeed - 4 Sep 2014
Geneia Inks Multi-Year Partnership with Covidien to Enter $21 Billion Remote Patient Monitoring Market
Devices Monitoring

HSMN NewsFeed - 18 Aug 2014
Boston Therapeutics Appoints Noted Diabetes Specialist Jaime A. Davidson, M.D. to Its Medical Advisory Board
Biopharmaceuticals Endocrinology Personnel

HSMN NewsFeed - 11 Aug 2014
Sanofi and MannKind Announce Global Licensing Agreement for Afrezza(R) (insulin human) Rapid-Acting Inhaled Insulin
Biopharmaceuticals Endocrinology Drug Delivery Licensing

HSMN NewsFeed - 5 Aug 2014
Boston Therapeutics Expands Medical Advisory Board
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Jul 2014
Integrity Applications, Inc. announces first wholesale orders for its GlucoTrack(R) model DF-F glucose measurement device and the hiring of a Director of Marketing and Sales
Devices Monitoring Endocrinology Personnel

HSMN NewsFeed - 22 Apr 2014
Cellnovo Strengthens Senior Management Team with Three Key Hires
Devices Endocrinology Personnel

HSMN NewsFeed - 14 Apr 2014
Abbott Announces FDA Clearance for a New Test to Help Physicians Quickly and Accurately Diagnose Diabetes
Diagnostics Endocrinology FDA

HSMN NewsFeed - 3 Apr 2014
Omnis Health Introduces EmbracePro(TM) – Professional Blood Glucose Meter
Devices Monitoring Endocrinology Product Launch

HSMN NewsFeed - 3 Mar 2014
U.S. FDA Approves Bydureon(R) Pen (exenatide extended-release for injectable suspension) for Once-Weekly Treatment of Adults with Type 2 Diabetes
Biopharmaceuticals Drug Delivery Endocrinology FDA

HSMN NewsFeed - 25 Feb 2014
Boston Therapeutics Appoints Larry K. Ellingson, Former Chair of the American Diabetes Association, as Chair of Its Scientific Advisory Board
Biopharmaceuticals Endocrinology Personnel

HSMN NewsFeed - 4 Feb 2014
LabStyle Innovation Signs Agreement with uHealth to Exclusively Distribute the Dario(TM) Blood Glucose Monitoring Device in Australia
Devices Monitoring Endocrinology Distribution

HSMN NewsFeed - 29 Jan 2014
Integrity Applications Signs Third Distribution Agreement for GlucoTrack(R) Model DF-F Glucose Monitoring Device
Devices Monitoring Endocrinology Distribution

HSMN NewsFeed - 13 Jan 2014
Integrity Applications Signs Distribution Agreement for GlucoTrack(R) Model DF-F Glucose Monitoring Device
Devices Monitoring Endocrinology Distribution

HSMN NewsFeed - 31 Dec 2013
Miraculins and Cachet Pharmaceutical Agree to 30-Day Extension on Letter of Intent to Continue Negotiation of Licensing Rights for SCOUT DS(R) Diabetes Test in China
Diagnostics Endocrinology Licensing

HSMN NewsFeed - 19 Dec 2013
ViaCyte Appoints Mark Foletta, former CFO of Amylin, to its Board of Directors
Devices Regenerative Medicine Endocrinology Personnel

HSMN NewsFeed - 16 Dec 2013
MicroBiome Therapeutics(TM) Completes Bridge Financing
Biopharmaceuticals Endocrinology Venture Capital

HSMN NewsFeed - 10 Dec 2013
Insulet Announces Commercial Agreement With Amgen
Devices Drug Delivery Endocrinology

HSMN NewsFeed - 2 Dec 2013
Forest to Acquire U.S. Marketing Rights to Saphris(R) (asenapine) from Merck
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 26 Nov 2013
Echo Therapeutics Announces Positive CE Mark Regulatory Trial Results of Symphony(R) CGM System
Devices Monitoring Regulatory

HSMN NewsFeed - 30 Oct 2013
iHealth Announces Availability of Wireless Smart-Gluco Monitoring System
Devices Monitoring Product Launch

HSMN NewsFeed - 21 Oct 2013
Bayer's CONTOUR(R) NEXT LINK Cleared For Use With Medtronic's New MiniMed(R) 530G With Enlite(R)
Devices Drug Delivery Monitoring Endocrinology FDA

HSMN NewsFeed - 17 Sep 2013
Abbott Receives CE Mark for FreeStyle Optium Neo Blood Glucose and Ketone Monitoring System(TM)
Devices Diagnostics Monitoring Regulatory

HSMN NewsFeed - 28 Aug 2013
Study Demonstrates Glysure System's Ability to Accurately Measure Blood Glucose Levels in the ICU
Devices Surgery Monitoring

HSMN NewsFeed - 23 Aug 2013
Bosch Healthcare Reacquires the Rights to Its Patents in the Diabetes Field from Abbott
Devices Endocrinology Monitoring Licensing

HSMN NewsFeed - 25 Jul 2013
Abbott Receives FDA Clearance for FreeStyle Precision Pro Blood Glucose and Beta-Ketone Monitoring System(TM)
Devices Endocrinology Monitoring FDA

HSMN NewsFeed - 26 Jun 2013
GlySure Appoints William Moffitt as Executive Chairman
Devices Monitoring Personnel

HSMN NewsFeed - 5 Jun 2013
Echo Therapeutics Initiates CE Mark Clinical Trial of its Symphony(R) CGM System
Devices Monitoring Regulatory

HSMN NewsFeed - 9 May 2013
Abbott Announces CE Mark for Test to Aid Doctors with Diagnosing and Monitoring Diabetes
Diagnostics Endocrinology Regulatory

HSMN NewsFeed - 15 Apr 2013
Abbott Initiates Voluntary Recall of FreeStyle InsuLinx(R) Blood Glucose Meters in the United States
Devices Monitoring Endocrinology Product Recall

HSMN NewsFeed - 6 Mar 2013
GI Dynamics Announces Agreement with CMS Medical for Distribution of EndoBarrier(R) Therapy in Brazil
Devices Distribution

HSMN NewsFeed - 25 Feb 2013
First U.S. Patients Treated in PneumRx RENEW Pivotal Study for Treatment of Severe Emphysema
Devices

HSMN NewsFeed - 14 Dec 2012
Next-Generation OmniPod(R) Insulin Pump Cleared by FDA
Devices Drug Delivery Endocrinology FDA

HSMN NewsFeed - 13 Nov 2012
Boston Therapeutics Names Jonathan B.Rome Chief Operating Officer
Biopharmaceuticals Endocrinology Personnel

HSMN NewsFeed - 1 Nov 2012
NeuroMetrix Announces Distribution Agreement with OneSource Medical Group for SENSUS Pain Management Device
Devices Endocrinology Distribution

HSMN NewsFeed - 29 Oct 2012
ViaCyte Appoints Steve Altman to its Board of Directors
Regenerative Medicine Endocrinology Personnel

HSMN NewsFeed - 8 Oct 2012
U.S. FDA Approves the Dexcom G4(TM) PLATINUM Continuous Glucose Monitor (CGM)
Devices Endocrinology Monitoring FDA

HSMN NewsFeed - 8 Oct 2012
Hygieia’s d-Nav(TM) Receives CE Mark; First DIGS(TM) Use on U.K. Horizon
Devices Monitoring Endocrinology Regulatory

HSMN NewsFeed - 4 Oct 2012
Boston Therapeutics Wins FDA Approval to File an Abbreviated New Drug Application for PAZAMET(TM) to Treat Diabetes
Biopharmaceuticals Endocrinology FDA

HSMN NewsFeed - 1 Oct 2012
Roche Diagnostics ACCU-CHEK Combo Insulin Pump System Now Available in United States
Devices Monitoring Drug Delivery Endocrinology

HSMN NewsFeed - 26 Jul 2012
Insulet Appoints W. Mark Lortz to Board of Directors
Devices Endocrinology Personnel

HSMN NewsFeed - 10 Jul 2012
Abbott Announces New Test for the Management of Patients with Diabetes
Diagnostics Endocrinology Regulatory

HSMN NewsFeed - 15 Jun 2012
ViaCyte Appoints Dr. Paul Laikind Chief Executive Officer
Regenerative Medicine Personnel

HSMN NewsFeed - 6 Jun 2012
ORENCIA(R) (abatacept) Demonstrates Comparable Efficacy to Humira(R) (adalimumab) in Patients with Moderate to Severe Rheumatoid Arthritis in First Head-to-Head Study of These Agents
Biopharmaceuticals

HSMN NewsFeed - 19 Apr 2012
GI Dynamics Announces First Cases of EndoBarrier(R) Therapy in Australia
Devices Gastroenterology

HSMN NewsFeed - 11 Apr 2012
Insulet Expands International Distribution Partnership With Ypsomed
Devices Drug Delivery Endocrinology Distribution

HSMN NewsFeed - 29 Feb 2012
Study of Next Step Toward Artificial Pancreas from Medtronic Meets Efficacy Endpoints
Devices Endocrinology Drug Delivery Monitoring

HSMN NewsFeed - 6 Dec 2011
Echo Therapeutics Announces Positive Results of Clinical Trial of its Symphony(R) Transdermal Continuous Glucose Monitoring (tCGM) System in Patients With Type 1 and Type 2 Diabetes
Devices Endocrinology Monitoring

HSMN NewsFeed - 29 Nov 2011
SweetSpot Diabetes Care Receives FDA 510(k) Clearance for SweetSpot Diabetes Data Management Service
Devices Monitoring Endocrinology FDA

HSMN NewsFeed - 11 Oct 2011
Echo Therapeutics Hires Product Development Management Executive
Devices Monitoring Personnel

HSMN NewsFeed - 6 Oct 2011
Echo Therapeutics Announces Positive Results of Clinical Trial of Its Symphony(R) Continuous Glucose Monitoring System
Devices Monitoring

HSMN NewsFeed - 19 Sep 2011
OptiScan Biomedical Receives CE Mark for OptiScanner Automatic Bedside Glucose Monitoring System
Devices Monitoring Regulatory

HSMN NewsFeed - 2 Aug 2011
Echo Therapeutics Hires Seasoned Diabetes Management Executive
Devices Monitoring Endocrinology Personnel

HSMN NewsFeed - 1 Aug 2011
Intuity Medical Closes $76 Million Series D Financing
Devices Venture Capital

HSMN NewsFeed - 2 Jun 2011
Animas(R) Vibe, the First Integrated Offering from Animas Corporation and Dexcom, Inc., Receives European CE Mark Approval
Devices Monitoring Drug Delivery Regulatory

HSMN NewsFeed - 9 May 2011
Medtronic and Bayer HealthCare Expand International Alliance
Devices Endocrinology

HSMN NewsFeed - 11 Apr 2011
Medtronic Launches More Accurate and Comfortable Sensor to Help Improve Glucose Control
Devices Monitoring Endocrinology

HSMN NewsFeed - 11 Mar 2011
Tolerx and GlaxoSmithKline Announce Phase 3 Defend-1 Study of Otelixizumab in Type 1 Diabetes Did Not Meet Its Primary Endpoint
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 10 Jan 2011
Insulet Appoints Charles Liamos as Chief Operating Officer
Devices Endocrinology Personnel

HSMN NewsFeed - 13 Dec 2010
Medtronic Launches CareLink Pro 3.0, the First Diabetes Management Software to Offer Advanced Decision Support
Devices Endocrinology FDA

HSMN NewsFeed - 11 Oct 2010
Alphatec Holdings Announces Appointment of Michael O'Neill, FCMA, as Chief Financial Officer
Devices Orthopaedic Neurosurgery Personnel

HSMN NewsFeed - 11 Oct 2010
Exelixis Licenses Programs to Bristol-Myers Squibb Company
Biopharmaceuticals Licensing

HSMN NewsFeed - 2 Aug 2010
EnteroMedics Achieves Major Milestones in Global Regulatory and Commercialization Strategy for the Maestro System
Devices Gastroenterology FDA

HSMN NewsFeed - 1 Jul 2010
Phase III Study Shows Novartis Drug Afinitor(R) More Than Doubles Time Without Tumor Growth in Advanced Pancreatic NET Patients
Biopharmaceuticals Oncology

HSMN NewsFeed - 29 Jun 2010
New Lancing System Delivers More Comfortable Blood Glucose Testing(1)
Devices Endocrinology

HSMN NewsFeed - 25 Jun 2010
Medtronic Begins Enrollment in ASPIRE Pivotal Study of Low Glucose Suspend Integrated System
Devices Endocrinology

HSMN NewsFeed - 24 Jun 2010
FDA Approves Merck's DULERA(R) (mometasone furoate and formoterol fumarate dihydrate) Inhalation Aerosol for the Treatment of Asthma in Patients 12 Years of Age and Older
Biopharmaceuticals FDA

HSMN NewsFeed - 3 Jun 2010
Pivotal Phase III Trial of Novartis Drug Afinitor(R) Met Primary Endpoint in Study of Patients With Advanced Pancreatic Neuroendocrine Tumors
Biopharmaceuticals Oncology

HSMN NewsFeed - 18 May 2010
AccuVein Signs Exclusive Distribution Agreement in India to Sell Vein Illumination Device
Devices Distribution

HSMN NewsFeed - 29 Apr 2010
Ipsen's Partner Roche Announces That Taspoglutide Meets Its Primary Endpoint in a Key Phase III Clinical Trial
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 27 Apr 2010
Wound Management Technologies, Inc. Announces Collaboration Project for Diabetic Disease Management
Devices Wound Care

HSMN NewsFeed - 22 Feb 2010
EnteroMedics Appoints Dr. Scott Shikora as Consulting Chief Medical Officer
Devices Personnel

HSMN NewsFeed - 28 Jan 2010
Ligand Completes Acquisition of Metabasis
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 28 Jan 2010
EnteroMedics Announces Regulatory Path Forward Following FDA Meeting
Devices Gastroenterology FDA

HSMN NewsFeed - 26 Jan 2010
Novo Nordisk's Victoza(R) Receives FDA Approval for Adults With Type 2 Diabetes
Biopharmaceuticals Endocrinology FDA

HSMN NewsFeed - 25 Jan 2010
Calibra Receives 510(k) Clearance for the Finesse Insulin Patch-Pen, a Novel Way to Deliver Insulin
Devices Drug Delivery Endocrinology FDA

HSMN NewsFeed - 6 Jan 2010
T2 BioSystems Appoints Ken Toso Vice President, Product Development
Diagnostics Personnel

HSMN NewsFeed - 5 Jan 2010
Cardium to Launch MedPodium(TM) Product Line Initially Covering Six New Advanced Foot Care Products for Podiatry Patients to Complement the Excellagen Platform
Devices Wound Care

HSMN NewsFeed - 5 Jan 2010
Intuity Medical Closes $64 Million Series D Financing - One of the Largest Medical Device Funding Events of 2009
Devices Monitoring Endocrinology Venture Capital

HSMN NewsFeed - 30 Dec 2009
Biodel Submits VIAject(R) New Drug Application to FDA for Treatment of Diabetes
Biopharmaceuticals Drug Delivery Endocrinology FDA

HSMN NewsFeed - 29 Dec 2009
American Diabetes Association's New Clinical Practice Recommendations Promote A1C as Diagnostic Test for Diabetes
Diagnostics Endocrinology

HSMN NewsFeed - 14 Dec 2009
FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults
Biopharmaceuticals FDA

HSMN NewsFeed - 4 Dec 2009
FDA Approves Lilly's Zyprexa for Two Adolescent Indications
Biopharmaceuticals FDA

HSMN NewsFeed - 4 Dec 2009
US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder
Biopharmaceuticals FDA

HSMN NewsFeed - 1 Dec 2009
DiaMedica Proposes to Expand Into Neurological and Other Disorders Through Acquisition of Sanomune
Biopharmaceuticals Neurology Mergers & Acquisitions

HSMN NewsFeed - 2 Nov 2009
Pico-Tesla Starts Pilot Study for Type 2 Diabetes with its Proprietary Magnetic (Magneceutical) Therapy
Devices Endocrinology

HSMN NewsFeed - 27 Oct 2009
Ligand to Acquire Metabasis for Cash and Contingent Value Rights
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 21 Oct 2009
Wellstat Therapeutics and sanofi-aventis Enter Agreement on Novel Therapy for Type II Diabetes
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 20 Oct 2009
New Data Describe Safety of Subcutaneous Administration of ORENCIA(R) (abatacept) For Patients with Moderate to Severe Rheumatoid Arthritis
Biopharmaceuticals

HSMN NewsFeed - 12 Oct 2009
Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt(TM), an FDA-Approved Oral Therapy for Schizophrenia
Biopharmaceuticals Licensing

HSMN NewsFeed - 12 Oct 2009
Vanda Pharmaceuticals Enters into an Exclusive License Agreement for the Commercialization and Development of Fanapt(TM) in the U.S. and Canada for the Treatment of Schizophrenia
Biopharmaceuticals Licensing

HSMN NewsFeed - 14 Sep 2009
Schering-Plough Reports Data From SAPHRIS(R) (asenapine) Long-Term Schizophrenia Relapse Prevention Study
Biopharmaceuticals

HSMN NewsFeed - 26 Aug 2009
Updated ORENCIA(R) (abatacept) Labeling Includes Data to Support Earlier Use in Adult Patients with Moderate to Severe Rheumatoid Arthritis
Biopharmaceuticals

HSMN NewsFeed - 9 Jun 2009
Roche to Commence Phase III Trials with Innovative Treatment Designed to Lower Cardiovascular Risk in Diabetes Patients with Recent Heart Attack
Biopharmaceuticals Endocrinology Cardiology

HSMN NewsFeed - 18 May 2009
FDA Grants Approval for Use of RISPERDAL(R) CONSTA(R) as Both a Monotherapy and Adjunctive Therapy in the Maintenance Treatment of Bipolar I Disorder
Biopharmaceuticals FDA

HSMN NewsFeed - 13 May 2009
FDA Approves ACTOplus met(R) XR (pioglitazone HCl and metformin HCl extended-release) Tablets for the Treatment of Type 2 Diabetes
Biopharmaceuticals Endocrinology FDA

HSMN NewsFeed - 12 May 2009
Roche Announces Long-Term Commitment to Tackle Growing Epidemic of Diabetes
Biopharmaceuticals Diagnostics Monitoring Endocrinology

HSMN NewsFeed - 5 May 2009
Merck Serono Launches Glucophage Powder in First European Countries
Biopharmaceuticals Endocrinology Regulatory

HSMN NewsFeed - 20 Apr 2009
Apidra(R) SoloSTAR(R), the Easy-to-Use Insulin Delivery Device from sanofi-aventis, Now Available in the United States
Devices Biopharmaceuticals Drug Delivery Endocrinology

HSMN NewsFeed - 24 Mar 2009
Biodel to Submit New Drug Application for VIAject to FDA
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 23 Mar 2009
FDA Approves Symbyax(R) as First Medication for Treatment-Resistant Depression
Biopharmaceuticals FDA

HSMN NewsFeed - 19 Mar 2009
Inverness Medical Innovations Agrees to Acquire 'Second Territory' Rapid Diagnostics Business of ACON
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 10 Mar 2009
Tolerx Expands Phase 3 'DEFEND' Trial of Otelixizumab in Europe
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 26 Feb 2009
FDA Approves Apidra(R) SoloSTAR(R) - a Prefilled Disposable Insulin Pen
Biopharmaceuticals Drug Delivery Endocrinology FDA

HSMN NewsFeed - 23 Feb 2009
AstraZeneca Announces SEROQUEL XR is Now Available to Treat Bipolar Depression
Biopharmaceuticals

HSMN NewsFeed - 9 Feb 2009
ARKRAY USA Receives FDA Clearance on GLUCOCARD(R) 01-mini Blood Glucose Monitoring System
Devices Monitoring Endocrinology FDA

HSMN NewsFeed - 19 Jan 2009
Abbott Receives FDA CLIA Waiver for Use of Five Additional Cartridges on the i-STAT Handheld Blood Analyzer
Devices Diagnostics

HSMN NewsFeed - 15 Jan 2009
Lilly Resolves Investigations of Past Zyprexa Marketing and Promotional Practices
Biopharmaceuticals

HSMN NewsFeed - 24 Nov 2008
David R. King Joins Diasome Pharmaceuticals as Chairman of the Board
Biopharmaceuticals Endocrinology Drug Delivery Personnel

HSMN NewsFeed - 5 Nov 2008
Akesis Pharmaceuticals Appoints Carl LeBel as CEO and Jay Lichter as Executive Chairman
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Nov 2008
TysonBio Officially Announces Its Entry into India
Devices Diagnostics

HSMN NewsFeed - 29 Oct 2008
FDA Approves Rapid-Acting Insulin Apidra(R) for Treatment of Children with Diabetes
Biopharmaceuticals FDA Endocrinology

HSMN NewsFeed - 10 Oct 2008
FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania
Biopharmaceuticals FDA

HSMN NewsFeed - 8 Oct 2008
KCI Names New General Manager
Devices Wound Care Personnel

HSMN NewsFeed - 7 Oct 2008
Eli Lilly and Company Resolves Investigation Involving Numerous States
Biopharmaceuticals

HSMN NewsFeed - 26 Sep 2008
GI Dynamics Announces Promising Multi-Center Safety and Efficacy Data of EndoBarrier(TM) Gastrointestinal Liner for Pre-Surgical Weight Loss
Devices

HSMN NewsFeed - 26 Sep 2008
CHMP Recommends Approval of Olanzapine Long-acting Injection for Maintenance Treatment of Schizophrenia in Europe
Biopharmaceuticals Regulatory

HSMN NewsFeed - 8 Sep 2008
Major Study Reinforces the Power of Medtronic Device for Better Diabetes Management
Devices Endocrinology

HSMN NewsFeed - 3 Sep 2008
Insulet Appoints Bill Arthur as Vice President of Business Development
Devices Personnel

HSMN NewsFeed - 30 Jun 2008
Akesis Pharmaceuticals Names Carl LeBel as President and Chief Operating Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Jun 2008
ARKRAY USA Receives FDA Clearance on GLUCOCARD(TM) 01 Blood Glucose Monitoring System
Devices Monitoring Endocrinology FDA

HSMN NewsFeed - 24 Jun 2008
FDA Approves PrandiMet(TM), a Replaglinide and Metformin Fixed-Dose Combination Tablet for Treatment of Type 2 Diabetes
Biopharmaceuticals FDA Endocrinology

HSMN NewsFeed - 12 Jun 2008
ORENCIA(R) (abatacept) Provided an Increasing Degree of Inhibition of Structural Damage Through Three Years in Adults with Moderate to Severe Rheumatoid Arthritis
Biopharmaceuticals

HSMN NewsFeed - 10 Jun 2008
Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 9 Jun 2008
Solianis' Non-Invasive Glucose Monitor Tracks Blood Glucose in Outpatient Study
Devices Endocrinology Monitoring

HSMN NewsFeed - 31 May 2008
New Analyses Presented at ASCO Reaffirmed Efficacy and Safety of TORISEL in Patients With Advanced Kidney Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 16 May 2008
Data from Pooled Analyses Demonstrates Welchol, Combined with Metformin- or Sulfonylurea-Based Therapy, Significantly Lowers Blood Glucose in Adults with Type 2 Diabetes
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 14 May 2008
FDA Approves AstraZeneca's Seroquel(R) for Maintenance Treatment in Bipolar Disorder
Biopharmaceuticals FDA

HSMN NewsFeed - 8 May 2008
AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines
Biopharmaceuticals

HSMN NewsFeed - 28 Apr 2008
Medtronic Announces FDA Clearance of New OneTouch(R) UltraLink(TM) Blood Glucose Meter
Devices Monitoring Endocrinology FDA

HSMN NewsFeed - 22 Apr 2008
Smiths Medical to Promote and Distribute Abbott's FreeStyle Navigator Continuous Glucose Monitoring System
Devices Endocrinology Distribution

HSMN NewsFeed - 15 Apr 2008
Diasome Pharmaceuticals Announces Series B Financing
Biopharmaceuticals Endocrinology Venture Capital

HSMN NewsFeed - 14 Apr 2008
Abbott FreeStyle Freedom(R) Lite Blood Glucose Monitoring System Now Available With No Coding for People With Diabetes
Devices Endocrinology

HSMN NewsFeed - 8 Apr 2008
U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older
Biopharmaceuticals FDA

HSMN NewsFeed - 2 Apr 2008
Sirtris Receives Orphan Drug Designation from U.S. Food and Drug Administration for Resveratrol in Mitochondrial Disorder, MELAS Syndrome
Biopharmaceuticals FDA

HSMN NewsFeed - 31 Mar 2008
New Data Showed ACTOS(R) (pioglitazone HCl) Prevented Progression of Atherosclerotic Plaque Volume in Patients With Type 2 Diabetes
Biopharmaceuticals Cardiology Endocrinology

HSMN NewsFeed - 24 Mar 2008
Medtronic Announces Sales Milestone of One Million Continuous Glucose Monitoring Sensors Worldwide
Devices Endocrinology Monitoring

HSMN NewsFeed - 18 Mar 2008
GlucoLight Corporation Raises Third Tranche Of ''C'' Round Financing
Devices Monitoring Venture Capital

HSMN NewsFeed - 18 Mar 2008
Luminous Medical, Inc. Secures $23.5 Million to Commercialize an Automated Blood Glucose Monitor for Critical Care Use
Devices Venture Capital

HSMN NewsFeed - 17 Mar 2008
enGene Inc. Completes US$6.4M Series A Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 13 Mar 2008
Lilly and Transition Therapeutics Announce Licensing and Collaboration Agreement
Biopharmaceuticals Licensing

HSMN NewsFeed - 13 Mar 2008
FDA Approves Abbott's FreeStyle Navigator(R) Continuous Glucose Monitoring System
Devices FDA Endocrinology

HSMN NewsFeed - 13 Mar 2008
Echo Therapeutics Announces Positive Results from Symphony(TM) Transdermal Continuous Glucose Monitoring System Study at Tufts Medical Center
Devices Monitoring Endocrinology

HSMN NewsFeed - 12 Mar 2008
Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release
Biopharmaceuticals

HSMN NewsFeed - 29 Feb 2008
U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)
Biopharmaceuticals FDA

HSMN NewsFeed - 29 Feb 2008
AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Major Depressive Disorder
Biopharmaceuticals

HSMN NewsFeed - 28 Feb 2008
FDA Issues Not-Approvable Letter for Lilly's Zyprexa(R) Long-Acting Injection (LAI) for Schizophrenia Treatment
Biopharmaceuticals FDA

HSMN NewsFeed - 14 Feb 2008
GlucoLight Corporation Raises Second Tranche of ''C'' Round Financing
Devices Monitoring Venture Capital

HSMN NewsFeed - 6 Feb 2008
FDA Advisory Committee Supports Efficacy and Safety of Zyprexa(R) Long-Acting Injection (LAI) for Schizophrenia Treatment
Biopharmaceuticals FDA

HSMN NewsFeed - 28 Jan 2008
MicroIslet Announces the Appointments of Dr. Chris Marsh as Lead Transplant Advisor, and Dr. Ronald Goldblum as Lead Clinical Development Consultant
Regenerative Medicine Personnel

HSMN NewsFeed - 21 Jan 2008
Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults With Type 2 Diabetes
Biopharmaceuticals Endocrinology FDA

HSMN NewsFeed - 19 Jan 2008
Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes
Biopharmaceuticals Endocrinology FDA

HSMN NewsFeed - 10 Jan 2008
DexCom(TM) Announces Joint Development Agreement with Animas Corporation
Devices Endocrinology

HSMN NewsFeed - 7 Jan 2008
SYMLIN Pen-Injector Devices Now Available
Biopharmaceuticals Drug Delivery Endocrinology

HSMN NewsFeed - 2 Jan 2008
Echo Therapeutics Starts Clinical Study of Its Symphony(TM) Continuous Transdermal Glucose Monitoring System
Devices Monitoring

HSMN NewsFeed - 19 Dec 2007
Ex-Hypoguard CEO to Lead WaveSense(TM) Sales and Marketing
Devices Personnel

HSMN NewsFeed - 6 Dec 2007
Pelikan Technologies Closes $69 Million Series F Financing and Secures a Further $20 Million in Debt Financing
Devices Venture Capital

HSMN NewsFeed - 28 Nov 2007
MetaCure(TM) Launches Investigational Study of Gastric Stimulator for Patients With Type 2 Diabetes Who are Overweight
Devices

HSMN NewsFeed - 20 Nov 2007
U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) as the First Medication for Add-On Treatment of Major Depressive Disorder (MDD)
Biopharmaceuticals FDA

HSMN NewsFeed - 19 Nov 2007
Novo Nordisk Inc. Announces Exclusive Agreement With Sciele Pharma, Inc. to Market Prandin(R)
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 19 Nov 2007
Sciele Signs Exclusive Agreement with Novo Nordisk to Market Prandin(R) and PrandiMet(R)
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 16 Nov 2007
DexCom(TM) Receives FDA Approval to Calibrate Its SEVEN(TM) Continuous Glucose Monitoring System Using Any FDA Cleared Blood Glucose Meter
Devices Diagnostics FDA

HSMN NewsFeed - 16 Nov 2007
SEROQUEL XR(TM) Receives Approval From FDA for Maintenance Treatment of Schizophrenia
Biopharmaceuticals FDA

HSMN NewsFeed - 15 Nov 2007
ABILIFY(R) (aripiprazole) Supplemental New Drug Application for the Treatment of Pediatric Patients with Bipolar I Disorder Accepted for Priority Review by the U.S. Food and Drug Administration
Biopharmaceuticals FDA

HSMN NewsFeed - 9 Nov 2007
Five-Year Data Demonstrate Long-Term Efficacy and Safety with ORENCIA(R) (abatacept) in Adults with Rheumatoid Arthritis Who had an Inadequate Response to Methotrexate
Biopharmaceuticals

HSMN NewsFeed - 6 Nov 2007
U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for Adolescent Patients With Schizophrenia
Biopharmaceuticals FDA

HSMN NewsFeed - 1 Nov 2007
Ex-Head of Menarini Diabetes Unit Launches WaveSense Europe
Devices Personnel

HSMN NewsFeed - 23 Oct 2007
GlaxoSmithKline and Tolerx Form Worldwide Collaboration for Development and Commercialization of Novel Medication
Biopharmaceuticals

HSMN NewsFeed - 18 Oct 2007
Isis Adds New Drug to Its Development Pipeline: ISIS 388626 Targeting SGLT2 for the Treatment of Type 2 Diabetes
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 5 Oct 2007
Lilly Announces Updates to the Zyprexa and Symbyax U.S. Labels
Biopharmaceuticals

HSMN NewsFeed - 2 Oct 2007
Isis Earns $5 Million Milestone Payment From Ortho-McNeil, Inc. for Initiation of Phase 1 Study of ISIS 325568
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 1 Oct 2007
FDA Approves SYMLIN Pen-Injector Devices Offering Convenience and Accuracy for SYMLIN Use
Devices Drug Delivery Endocrinology FDA

HSMN NewsFeed - 27 Sep 2007
VeraLight Names Mirasol Panlilio VP Marketing and Sales
Devices Endocrinology Personnel

HSMN NewsFeed - 21 Sep 2007
Norditropin(R) Approved for Treatment of Children with Short Stature Associated with Turner Syndrome
Biopharmaceuticals FDA

HSMN NewsFeed - 19 Sep 2007
ACTOS(R) (pioglitazone HCl) Demonstrates Reduced Risk of Ischemic Cardiovascular Disease in Patients With Type 2 Diabetes
Biopharmaceuticals Endocrinology Cardiology

HSMN NewsFeed - 11 Sep 2007
Takeda Statement on ACTOS(R) (pioglitazone HCl) Meta-Analysis Published in the Journal of the American Medical Association
Biopharmaceuticals Endocrinology Cardiology

HSMN NewsFeed - 4 Sep 2007
Nebivolol Lowers Blood Pressure in Mild-to-Moderate Hypertensive Patients as Demonstrated in a Study Published in the Journal of Clinical Hypertension
Biopharmaceuticals

HSMN NewsFeed - 28 Aug 2007
Medco Announces Agreement to Acquire Diabetes Care Leader PolyMedica in Transaction Valued at $1.5 Billion
Biopharmaceuticals Endocrinology Mergers & Acquisitions

HSMN NewsFeed - 23 Aug 2007
RTX Healthcare Receives FDA 510k Market Clearance for Telehealth Monitor
Devices Monitoring FDA

HSMN NewsFeed - 22 Aug 2007
GlucoLight Successfully Completes First Hypoglycemic ''Clamping'' Study of Sentris-100(TM)
Devices Monitoring Endocrinology

HSMN NewsFeed - 21 Aug 2007
Medtronic and Bayer Diabetes Care Announce Alliance to Provide Blood Glucose Meter to Medtronic Patients Outside the United States
Devices Monitoring Endocrinology

HSMN NewsFeed - 21 Aug 2007
Medtronic Announces Alliance with LifeScan to Bring Leading Blood Glucose Meter to Its Diabetes Patients in United States
Devices Endocrinology

HSMN NewsFeed - 20 Aug 2007
Elixir Pharmaceuticals Initiates Final Phase III Clinical Study Prior to NDA
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 7 Aug 2007
ORENCIA(R) (abatacept) Supplemental Biologics License Application for Juvenile Idiopathic Arthritis Accepted by FDA for Filing and Review
Biopharmaceuticals FDA

HSMN NewsFeed - 31 Jul 2007
Home Diagnostics Appoints Senior Vice President of Sales and Marketing
Devices Diagnostics Personnel

HSMN NewsFeed - 31 Jul 2007
FDA Clears New GlucosePilot(TM) Blood Glucose Meter System
Devices Monitoring FDA Endocrinology

HSMN NewsFeed - 30 Jul 2007
SoloSTAR(R), the First Prefilled Disposable Insulin Pen for Lantus(R), is Now Available in the United States
Biopharmaceuticals Endocrinology Drug Delivery

HSMN NewsFeed - 17 Jul 2007
ABILIFY(R) (aripiprazole) Supplemental New Drug Application Receives Priority Review by U.S. Food And Drug Administration for Adjunctive Treatment in Adults With Major Depressive Disorder
Biopharmaceuticals FDA

HSMN NewsFeed - 16 Jul 2007
ARKRAY USA Launches PocketChem(TM)EZ Blood Glucose Monitoring System
Diagnostics

HSMN NewsFeed - 12 Jul 2007
FDA Grants CLIA Waived Status to Cholestech for New Combined Test Panel
Diagnostics FDA

HSMN NewsFeed - 29 Jun 2007
Rimonabant Regulatory Update in the United States
Biopharmaceuticals

HSMN NewsFeed - 25 Jun 2007
New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes Using Self-Adjusted Dosing Starting With Once-Daily Insulin Treatment Levemir(R)
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 24 Jun 2007
BYETTA(R) Study Showed Comparable Blood Glucose Control to Insulin
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 23 Jun 2007
Results of Two Head-to-Head Studies Demonstrated Long-Acting Insulin Lantus(R) Lowered Free Fatty Acid Levels Equal to or Better Than Thiazolidinediones
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 23 Jun 2007
BYETTA(R) Treatment for Three and a Half Years Associated with Reductions in Cardiovascular Risk Factors in People with Type 2 Diabetes
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 22 Jun 2007
Medtronic Unveils New Advanced Diabetes Therapy Management Software at 67th Annual American Diabetes Association Meeting
Devices Endocrinology

HSMN NewsFeed - 20 Jun 2007
OrSense Receives European CE Mark Approval for Continuous Non-Invasive Glucose Monitoring System
Devices Regulatory Monitoring Endocrinology

HSMN NewsFeed - 18 Jun 2007
ARKRAY USA Launches Assure(R) 4 Blood Glucose Monitoring System
Devices Monitoring

HSMN NewsFeed - 15 Jun 2007
Investigational Study Demonstrated a Re-Establishment of Clinical Improvement with Orencia(R) (Abatacept) in Children with Juvenile Idiopathic Arthritis upon Re-Introduction of Therapy
Biopharmaceuticals

HSMN NewsFeed - 15 Jun 2007
FDA Approves New Route of Administration for Rapid-Acting Apidra(R) Providing an Additional Treatment Option for Hospitalized Diabetes Patients with High Blood Sugar Levels
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 14 Jun 2007
Living Cell Technologies Announces First Diabetes Patient Successfully Dosed in Phase I/IIa DiabeCell(R) Trial
Regenerative Medicine Endocrinology

HSMN NewsFeed - 6 Jun 2007
Takeda Revises ACTOS(R) (pioglitazone HCl) Prescribing Label
Biopharmaceuticals Endocrinology FDA

HSMN NewsFeed - 6 Jun 2007
Statement of Moncef Slaoui, PhD, Chairman Research & Development GlaxoSmithKline
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 6 Jun 2007
Amgen to Acquire Alantos Pharmaceuticals, a Private Biotechnology Company in Cambridge, Massachusetts
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 6 Jun 2007
Abbott Receives European CE Mark Approval for FreeStyle Navigator(R) Continuous Glucose Monitoring System
Devices Monitoring Endocrinology Regulatory

HSMN NewsFeed - 1 Jun 2007
FDA Approves Norditropin(R)for Treatment of Short Stature Associated with a Rare Genetic Disorder
Biopharmaceuticals FDA

HSMN NewsFeed - 22 May 2007
GlucoLight Corporation Announces Successful Completion of First ICU Clinical Study
Devices Monitoring

HSMN NewsFeed - 21 May 2007
Milestone Scientific Forms New Medical Division and Appoints Former Bayer Senior Executive as Its CEO
Devices Drug Delivery Personnel

HSMN NewsFeed - 18 May 2007
FDA Approves Astrazeneca's Once-Daily Seroquel XR(TM) Extended-Release Tablets for the Treatment of Schizophrenia
Biopharmaceuticals FDA

HSMN NewsFeed - 9 May 2007
New AHA Guidelines Increase the Number of Children and Adolescents Recommended for Cholesterol Screening
Diagnostics Cardiology

HSMN NewsFeed - 30 Apr 2007
Insmed Releases Positive Results from IPLEX Phase II HIV-Associated Adipose Redistribution Syndrome Clinical Study
Biopharmaceuticals HIV/AIDS

HSMN NewsFeed - 30 Apr 2007
FDA Approves Lantus SoloStar(R) - A New Prefilled Disposable Insulin Pen For Use With LANTUS(R) In People With Type 1 And Type 2 Diabetes
Biopharmaceuticals Endocrinology Drug Delivery FDA

HSMN NewsFeed - 19 Apr 2007
Metabolex Raises $32 Million to Accelerate Clinical Development Programs for Its Pipeline of Drug Candidates in Metabolic Disease
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 17 Apr 2007
GTx Announces Ostarine(TM) Improved Insulin Resistance among Elderly Patients in a Recently Completed Phase II Clinical Trial
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 16 Apr 2007
Abbott Announces FDA Clearance and Launch of New FreeStyle Lite(TM) Blood Glucose Monitoring System
Devices Monitoring Endocrinology FDA

HSMN NewsFeed - 16 Apr 2007
Whole Blood Viscosity to Be Employed for Complications of Type II Diabetes
Devices Cardiology Endocrinology

HSMN NewsFeed - 12 Apr 2007
XOMA Announces Clinical Trial Plans for XOMA 052 in Type 2 Diabetes
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 9 Apr 2007
FDA approves Cangene's HepaGam B(TM) for a second indication; for use in hepatitis B-positive liver transplant recipients
Biopharmaceuticals FDA

HSMN NewsFeed - 6 Apr 2007
FDA approves Cangene's HepaGam B(TM) for a second indication; for use in hepatitis B-positive liver transplant recipients
Biopharmaceuticals FDA

HSMN NewsFeed - 4 Apr 2007
Protemix Raises US$14.5 Million in First Close of Series A Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 2 Apr 2007
FDA Approves JANUMET(TM) for Type 2 Diabetes, Offering Powerful Glucose Control of a DPP-4 Inhibitor and Metformin in a Single Tablet
Biopharmaceuticals FDA Endocrinology

HSMN NewsFeed - 19 Mar 2007
Medtronic Launches New Guardian(R) REAL-Time System with Miniature Transmitter and CareLink(TM) Personal Software
Devices Endocrinology

HSMN NewsFeed - 19 Mar 2007
Cepheid's Xpert(TM) EV Test for Enteroviral Meningitis, Run on the GeneXpert Platform, Receives FDA Clearance
Diagnostics FDA

HSMN NewsFeed - 12 Mar 2007
FDA Approves New Medtronic Continuous Glucose Monitoring Devices for Children and Teenagers
Devices FDA Endocrinology

HSMN NewsFeed - 7 Mar 2007
The University of Texas Licenses Drug Delivery Technology to Newly Formed Mimetic Solutions, LLC
Biopharmaceuticals Drug Delivery Licensing

HSMN NewsFeed - 1 Mar 2007
Study Confirms That Significant Insulin Dose Errors Can Result When Blood Glucose Meters are Miscoded
Devices Monitoring Endocrinology

HSMN NewsFeed - 22 Feb 2007
Lilly Introduces World's First Digital Insulin Pen With Memory
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 20 Feb 2007
New Storage Instructions Approved for BYETTA(R)
Biopharmaceuticals Endocrinology FDA

HSMN NewsFeed - 20 Feb 2007
Steven T. Sobieski Joins Insulet Corporation's Board of Directors
Devices Drug Delivery Personnel

HSMN NewsFeed - 15 Feb 2007
Insulet Corporation Promotes Luis Malave to Chief Operating Officer
Devices Drug Delivery Personnel

HSMN NewsFeed - 15 Feb 2007
FDA Accepts Two Supplemental New Drug Applications to Expand the U.S. Labeling for JANUVIA(TM)
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 8 Feb 2007
Cholestech Corporation Launches New Dermatology Kit for In-office Cholesterol, Liver and Pregnancy Screening
Diagnostics Dermatology

HSMN NewsFeed - 31 Jan 2007
Hospitals, Healthcare Providers to Save with Premier Blood Glucose Meters, Reagents, Consumables, Service Agreements
Diagnostics Group Purchasing

HSMN NewsFeed - 30 Jan 2007
Home Diagnostics Appoints Vice President of Marketing
Diagnostics Personnel

HSMN NewsFeed - 24 Jan 2007
Zylera Pharmaceuticals Announces Availability of RELAMINE for the Treatment of Osteoarthritis
Biopharmaceuticals

HSMN NewsFeed - 18 Jan 2007
Abbott To Sell Its Core Laboratory Diagnostics Business, Including Point Of Care, To GE For $8.13 Billion
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 17 Jan 2007
Elixir Pharmaceuticals Presents New Data Highlighting Ghrelin Inhibition as a Potential Method for Regulating Metabolism and Treating Diabetes
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 11 Jan 2007
Bristol-Myers Squibb and AstraZeneca Announce Worldwide Collaboration to Develop and Commercialize Diabetes Compounds
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 5 Jan 2007
OSI Pharmaceuticals Licenses Its Glucokinase Activator Program for the Treatment of Type 2 Diabetes to Eli Lilly and Company
Biopharmaceuticals Endocrinology Licensing

HSMN NewsFeed - 5 Jan 2007
Lilly and OSI Pharmaceuticals Announce Licensing Agreement
Biopharmaceuticals Endocrinology Licensing

HSMN NewsFeed - 3 Jan 2007
Genaera Corporation Terminates EVIZON(TM) Clinical Program and Restructures
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 3 Jan 2007
FDA Approves BYETTA(R) (exenatide) Injection for Expanded Combination Use
Biopharmaceuticals Endocrinology FDA

HSMN NewsFeed - 27 Dec 2006
Bristol-Myers Squibb and Otsuka Pharmaceutical Co., Ltd. Announce Exclusive Licensing Agreement for Diabetes Compound Saxagliptin in Japan
Biopharmaceuticals Endocrinology Licensing

HSMN NewsFeed - 22 Dec 2006
FDA Approves BYETTA(R) (exenatide) Injection for Expanded Combination Use
Biopharmaceuticals Endocrinology FDA

HSMN NewsFeed - 12 Dec 2006
ABILIFY(R) (Aripiprazole) Injection for Intramuscular Use for Adults With Agitation Associated With Schizophrenia or Bipolar Mania Now Available
Biopharmaceuticals

HSMN NewsFeed - 7 Dec 2006
ABILIFY(R) (aripiprazole) Demonstrated Efficacy as Long-Term Maintenance Therapy in Adults With Bipolar I Disorder Following Treatment for a Recent Manic Or Mixed Episode
Biopharmaceuticals

HSMN NewsFeed - 6 Dec 2006
New Evidence Reinforces Efficacy and Tolerability of Galvus(R) as a New Once-Daily Oral Treatment Option for Patients With Type 2 Diabetes
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 5 Dec 2006
New Data Shows Rimonabant Benefited Patients with Type 2 Diabetes by Improving Blood Sugar Control, Reducing Weight and Acting on Other Cardiometabolic Risk Factors
Biopharmaceuticals Endocrinology Cardiology

HSMN NewsFeed - 4 Dec 2006
Landmark Study Shows Avandia(R) (rosiglitazone maleate) Is More Effective Than Metformin or a Sulfonylurea in Long-Term Blood Sugar Control in Type 2 Diabetes
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 1 Dec 2006
Lilly Responds to the Cost-Effectiveness Analysis of the CATIE Schizophrenia Trial
Biopharmaceuticals

HSMN NewsFeed - 29 Nov 2006
RejuvaCell's Breakthrough Stem Cell Therapy Demonstrates Potential to Revolutionize Treatment for Type-2 Diabetes
Regenerative Medicine Endocrinology

HSMN NewsFeed - 28 Nov 2006
Cardiocom(TM) Announces New GlucoCom(TM) Division and Diabetes Product Sales Team
Devices Personnel

HSMN NewsFeed - 21 Nov 2006
BYETTA(R) (exenatide) Approved for Treatment of Type 2 Diabetes by European Commission
Biopharmaceuticals Endocrinology Regulatory

HSMN NewsFeed - 20 Nov 2006
FDA Clearance Received for CozMore(R) Insulin Technology System Updates
Devices Drug Delivery Endocrinology FDA

HSMN NewsFeed - 13 Nov 2006
New Data Show ACTOS(R) (pioglitazone HCl) Halted Progression of Atherosclerosis as Indicated by CIMT in Patients With Type 2 Diabetes
Biopharmaceuticals

HSMN NewsFeed - 6 Nov 2006
Significant Errors In Insulin Dose Can Result When Blood Glucose Meters Are Miscoded According to New Clinical Study
Devices Diagnostics Monitoring Endocrinology

HSMN NewsFeed - 20 Oct 2006
FDA Approves AstraZeneca's SEROQUEL(R) For Bipolar Depression Treatment
Biopharmaceuticals FDA

HSMN NewsFeed - 17 Oct 2006
FDA Approves Once-Daily JANUVIA(TM), the First and Only DPP-4 Inhibitor Available in the United States for Type 2 Diabetes
Biopharmaceuticals FDA Endocrinology

HSMN NewsFeed - 10 Oct 2006
MacroGenics Receives Orphan Drug Designation From FDA for Monoclonal Antibody to Treat Type 1 Diabetes
Biopharmaceuticals Endocrinology FDA

HSMN NewsFeed - 3 Oct 2006
Akesis Pharmaceuticals Hires Industry Executive as New CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Oct 2006
Alert for BD Logic(R) Meter Users: Roche Diagnostics Offers ACCU-CHEK(R) Blood Glucose Systems
Diagnostics Endocrinology

HSMN NewsFeed - 29 Sep 2006
Abbott to Provide a Free Blood Glucose Monitoring System to All Becton, Dickinson BD Logic(R) Patients
Devices Diagnostics Endocrinology

HSMN NewsFeed - 29 Sep 2006
Study Shows Non-Invasive Device Outperforms Fasting Plasma Glucose and A1C for Diabetes Screening
Devices Endocrinology

HSMN NewsFeed - 28 Sep 2006
BD Announces Plan to Exit Blood Glucose Monitoring Market
Devices Monitoring

HSMN NewsFeed - 18 Sep 2006
Type 2 Diabetes Patients on Technosphere Insulin Exhibited No Adverse Effect on Pulmonary Function with Significant HbA1c Reductions, and Showed Significant Weight Reduction Compared to Injected Insulin Analog
Biopharmaceuticals Drug Delivery Endocrinology

HSMN NewsFeed - 14 Sep 2006
OrSense's Non-Invasive Continuous Glucose Monitoring System Demonstrates Excellent Results in Home Use Setting
Devices Monitoring Endocrinology

HSMN NewsFeed - 14 Sep 2006
Study Shows Exenatide Improves Blood Sugar Levels as Effectively as Biphasic Insulin Aspart
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 14 Sep 2006
ACTOS(R) (pioglitazone HCl) Demonstrates Significant Improvements in Cardiovascular Outcomes for High-Risk Patients With Type 2 Diabetes
Biopharmaceuticals Endocrinology Cardiology

HSMN NewsFeed - 14 Sep 2006
New Phase III Data Showed Significant Glucose-Lowering Efficacy of JANUVIA(TM), an Investigational Medicine for Type 2 Diabetes, When Taken Simultaneously with Metformin
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 13 Sep 2006
One in Three Parents Surveyed Unaware of Easy Ketone Test That May Help Prevent the Onset of Diabetic Ketoacidosis (DKA)
Diagnostics Endocrinology

HSMN NewsFeed - 7 Sep 2006
Xenical(R) Shown to Improve Control of Blood Glucose Levels in People With Type 2 Diabetes Beyond Impact of Weight Loss Alone
Biopharmaceuticals

HSMN NewsFeed - 6 Sep 2006
Amlodipine Based Regimen to Lower Blood Pressure, Reduces the Risk of New-Onset Diabetes in Hypertensive Patients by More Than a Third
Biopharmaceuticals Cardiology

HSMN NewsFeed - 21 Jul 2006
Takeda Announces Start of Phase 3 Clinical Program in the U.S. of Fixed Dose Combination Product of Actos(R) + TAK-536 for Treatment of Patients with Type 2 Diabetes Associated with Hypertension
Biopharmaceuticals Endocrinology Cardiology

HSMN NewsFeed - 18 Jul 2006
AstraZeneca Submits NDA for Sustained Release Formulation of SEROQUEL(R) for Schizophrenia Treatment
Biopharmaceuticals FDA

HSMN NewsFeed - 17 Jul 2006
Medtronic Receives FDA Approval for Guardian(R) REAL-Time Continuous Glucose Monitoring System
Devices Endocrinology FDA

HSMN NewsFeed - 6 Jul 2006
Bayer Acquires Metrika Inc.
Devices Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 27 Jun 2006
GlucoTec, Inc. Receives FDA Clearance to Market GLUCOMMANDER(TM) PLUS Insulin Dosing System
Devices Endocrinology FDA

HSMN NewsFeed - 27 Jun 2006
Novo Nordisk Prevails in sanofi-aventis Challenge to Levemir(R) - Up to 24 Hours Duration of Action and Other Claims Upheld
Biopharmaceuticals Litigation

HSMN NewsFeed - 23 May 2006
Second Investigational Study of SEROQUEL(R) in the Treatment of Depressive Episodes Associated with Bipolar Disorder Confirms Previous Findings
Biopharmaceuticals

HSMN NewsFeed - 23 May 2006
New Study Suggests Symbyax(R) Significantly Improves Symptoms of Treatment-Resistant Depression
Biopharmaceuticals

HSMN NewsFeed - 23 May 2006
Topical Hedgehog Agonist Accelerates Wound Healing in Diabetes
Biopharmaceuticals Wound Care

HSMN NewsFeed - 22 May 2006
New Studies Examine SEROQUEL(R) in Combination With Antidepressant Therapy in Patients With Depression
Biopharmaceuticals

HSMN NewsFeed - 22 May 2006
First Head-to-Head Study Suggests Significantly Greater Symptom Improvement for Symbyax(R) Compared to Lamotrigine in Bipolar Depression
Biopharmaceuticals

HSMN NewsFeed - 16 May 2006
Manhattan Pharmaceuticals Receives SwissMedic's Approval to Commence Phase IIa Trial With OE, Its Oral Obesity Drug Candidate
Biopharmaceuticals

HSMN NewsFeed - 4 May 2006
PBI Technology, Inc. Signs License Agreement for SalivaSac(R) with Evergreen Innovation Partners
Devices Diagnostics Licensing

Return to NewsFeed

Additional items found! 256

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 256 additional stories matching:
Blood Glucose
(Password required)

FindReps - available on the Apple App Store for iPhone and iPad.